Raymond James Financial Services Advisors’s Cardlytics CDLX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,868	Closed	-$5.26M	–	3323
2023 Q3	$5.26M	Buy	+31,868	New	+$4.14M	0.01%	986
2021 Q3	–	Sell	-190	Closed	-$241K	–	3308
2021 Q2	$241K	Buy	+190	New	+$214K	﹤0.01%	2871
2021 Q1	–	Sell	-204	Closed	-$292K	–	3191
2020 Q4	$292K	Sell	204 -95	-32%	-$101K	﹤0.01%	2480
2020 Q3	$211K	Sell	299 -781	-72%	-$568K	﹤0.01%	2510
2020 Q2	$756K	Buy	+1,080	New	+$624K	﹤0.01%	1662
2020 Q1	–	Sell	-1,734	Closed	-$1.09M	–	2460
2019 Q4	$1.09M	Buy	1,734 +547	+46%	+$267K	﹤0.01%	1497
2019 Q3	$398K	Buy	+1,187	New	+$381K	﹤0.01%	2047

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

Raymond James Financial Services Advisors's CDLX Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 31,868 shares — an estimated $5.26M sold.

Raymond James Financial Services Advisors first reported a position in CDLX in Q3 2019 and held it in 7 quarters. The position peaked at $5.26M in Q3 2023. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

Raymond James Financial Services Advisors reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
Raymond James Financial Services Advisors sold 31,868 Cardlytics shares in Q4 2023, an estimated $5.26M.
Raymond James Financial Services Advisors first reported a position in Cardlytics in Q3 2019 and held it in 7 quarters.
Raymond James Financial Services Advisors's Cardlytics position peaked at $5.26M in Q3 2023.
124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.